MARKET

OTLKW

Outlook Therapeutics Inc
OTLKW
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-0.2941
0.0670
1.149
-
Outlook Therapeutics Inc <OTLK.OQ> expected to post a loss of 60 cents a share - Earnings Preview
Reuters · 16h ago
OUTLOOK THERAPEUTICS - FDA DETERMINED CLASS 2 REVIEW FOR OUTLOOK THERAPEUTICS' BLA FOR ONS-5010- SEC FILING
Reuters · 04/08 21:01
OUTLOOK THERAPEUTICS INC - PRESCRIPTION DRUG USER FEE ACT (PDUFA) GOAL DATE OF AUGUST 27, 2025
Reuters · 04/08 12:45
OUTLOOK THERAPEUTICS FILES PROSPECTUS COVERING OFFER & RESALE BY SELLING STOCKHOLDERS OF UP TO 21.7 MLN SHARES OF COMMON STOCK- SEC FILING
Reuters · 03/20 21:03
OUTLOOK THERAPEUTICS INC - FDA DECISION EXPECTED WITHIN SIX MONTHS
Reuters · 02/28 13:05
OUTLOOK THERAPEUTICS INC <OTLK.O>: GUGGENHEIM CUTS TARGET PRICE TO $10 FROM $12
Reuters · 02/19 11:29
OUTLOOK THERAPEUTICS, INC. <OTLK.O>: H.C. WAINWRIGHT CUTS TARGET PRICE TO $3 FROM $30
Reuters · 02/18 11:04
Outlook Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Reuters · 02/14 14:32
More

Webull offers Outlook Therapeutics Inc stock information, including NASDAQ: OTLKW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OTLKW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OTLKW stock methods without spending real money on the virtual paper trading platform.